NVO - Ozempic drives more demand for smaller clothes WSJ reports
2024-06-16 12:33:31 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- U.S. drug shortages worsen to reach a decade high: report
- Novo Nordisk CEO to testify before Senate on Ozempic pricing